Apolipoprotein Test Market

Apolipoprotein Test Market Overview

The global apolipoprotein test market was valued at around US$ 503.15 Million at the end of 2021. The market is projected to register a 7.6% CAGR and top a valuation of US$ 1,126.26 Million by 2032.

The growing geriatric population, altered diet and lifestyle patterns, and rising health awareness of various heart diseases are anticipated to propel market expansion in the near future.

Apolipoproteins are proteins that transport by binding to them. There are various different varieties of apolipoproteins, however the main protein forms that come from low-density lipoproteins are apolipoprotein B. (LDL). Apo B exists in humans in two different forms.

While Apo B48 is helpful in the observation of lipid-soluble nutrients and medications, Apo B100 aids in the evaluation of the risk of developing cardiovascular disease. Controlling cardiac problems is the responsibility of apo A and apo c3. Because most adults with high cholesterol have an elevated risk of acquiring cardiovascular illnesses, the apolipoprotein test market is anticipated to grow rapidly.

These examinations are carried out to identify cardiovascular illnesses' early-stage risk factors as early as possible. Due to rising risks of serious cardiac disorders like stroke and heart attack, the apolipoprotein test market is anticipated to rise rapidly.

According to the World Health Organization, heart attacks and strokes account for over 85% of all cardiovascular disease-related deaths, and about 17.9 million individuals worldwide pass away from CVDs each year. The two primary apolipoproteins, apoA and apoB, are primarily linked to CVD.

Attributes	Details
Apolipoprotein Test Market Value in 2021	US$ 503.15 Million
Apolipoprotein Test Market Value in 2032	US$ 1126.26 Million
Apolipoprotein Test Market CAGR (2022 to 2032)	7.6%

What are the Major Drivers Boosting the Demand for Apolipoprotein Test Market?

One of the key factors propelling the growth of the apolipoprotein test market is anticipated to be the rising need for diagnostic services in the developing world. The market for apolipoprotein tests may experience expansion due to increased awareness of the need of maintaining good cardiac health.

Apolipoprotein test demand is being boosted by a variety of major cardiovascular conditions such as coronary heart disease, high blood pressure, cardiac arrest, heart failure, stroke, and arrhythmia, as well as by many other diseases.

Most doctors, heart specialists, and other healthcare professionals now advise people with a personal family history of heart disease to get an apolipoprotein test. As a result, one of the key reasons propelling the market expansion for apolipoprotein testing is the referral of these tests by physicians to patients with a family history of heart disease.

Apolipoprotein testing is another recommendation made by doctors to people with elevated cholesterol levels. People typically perform apolipoprotein tests once or twice a year due to increasing knowledge of the risk of developing cardiac diseases and greater health education, this may also be a factor in the market expansion for apolipoprotein testing.

Which Region Shows Strong Growth Potential in the Apolipoprotein Test Market?

The apolipoprotein test market is broadly divided into seven major regions, North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.

North America dominated the regional apolipoprotein test market due to the high rates of obesity and high consumption of saturated fats among the people in US. Additionally, people in the USA often have higher expectations for diagnostic services and longer life spans. This is also projected to play a significant role in the market expansion for apolipoprotein tests in the United States.

Moreover, the market for apolipoprotein tests in the Asia-Pacific region is anticipated to expand at a rapid rate due to the rising incidence of CVD and the consequent rise in demand for diagnostic services, particularly given the high rates of heart disease in China and India.

Who are the Key Manufacturers in the Apolipoprotein Test Market?

Randox Laboratories Ltd., Abbott Laboratories, Danaher Corporation, Bio-Rad Laboratories Inc., OPKO Health Inc., Myriad Genetics Inc., Quest Diagnostics Inc., Eurofins Scientific, Lincoln Diagnostics LLC., DiaSorin S.p.A., Boster Biological Technology, Ltd., and Rockland Immunochemicals Inc.

Scope of Report

Report Attributes	Details
Growth Rate	CAGR of 7.6% 2022 to 2032
Base Year for Estimation	2021
Historical Data	2012 to 2021
Forecast Period	2022 to 2032
Qualitative Units	Revenue in USD Million, Volume in Units, and CAGR from 2022 to 2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segment Covered	Product Type Test Type End-User
Region Covered	North America Latin America Europe East Asia South Asia Oceania Middle East & Africa
Key Countries Profiled	USA Canada Brazil Mexico Argentina Germany United Kingdom France Spain Italy Russia China Japan South Korea India Malaysia Indonesia Thailand Australia New Zealand GCC Countries South Africa North Africa Turkey
Key Players	Randox Laboratories Ltd. Abbott Laboratories Danaher Corporation Bio-Rad Laboratories Inc. OPKO Health Inc. Myriad Genetics Inc. Quest Diagnostics Inc. Eurofins Scientific Lincoln Diagnostics LLC. DiaSorin S.p.A. Boster Biological Technology, Ltd. Rockland Immunochemicals Inc.
Customization	Available Upon Request

Key Segments Covered in the Apolipoprotein Test Market Survey

By Product Type:

• ELISA Kit
• Immuno-separation reagent kit
• Immunoassay kit

By Test Type:

• Apolipoprotein A
• Apo A-I
• Apo A-II
• Apolipoprotein B
• Apo B 100
• Apo B 48
• Apolipoprotein C
• Apolipoprotein D
• Apolipoprotein E

By End-User:

• Diagnostic Laboratories
• Hospitals
• Research Centers & Academic Institutes

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)